Skip to main content

Table 2 Table shows daemographic data, SVR (in months) and ADRs according to overall enrolled population, genotype (Gt) and disease stage (chirrosis and chronic hepatitis C F3 stage according to metavir)

From: Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist

 

CHIRROSIS

CHC

TOT

ADRs

20/51

15/27

35/78

Sex

M 44 – F 22

M 14 – F 4

M 58 - F 26

Age

<65: 10

<65: 17

<65: 27

>65:41

>65:11

>65:51

Genotype in overall population

 Gt 1

38

20

58

 Gt 2

9

5

14

 Gt 3

4

2

6

SVR in over all population

 SVR 3 mts

44/51

25/27

69/78

 SVR 6 mts

44/51

24/27

68/78

 RELAPSE

6/51

4/27

10/78